Evidence map›Paper›PMID 26882261›Full record

ReviewNature immunology2016

Inflammatory networks underlying colorectal cancer.

Audrey Lasry, Adar Zinger, Yinon Ben-Neriah

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03221920 (Effect of Very Low Carbohydrate Diet to Glasgow Prognostic Score, Serum Lactate and TNF Alpha on Colorectal Cancer Patients With Best Supportive Care), which is not on this map. Cited by 288 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 6 pooled it
29.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03221920 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Effect of Very Low Carbohydrate Diet to Glasgow Prognostic Score, Serum Lactate and TNF Alpha on Colorectal Cancer Patients With Best Supportive Care

TypeinterventionalSponsorDr. Soetomo General HospitalRan2017 to 2017Enrolled26ConditionsDiet Modification, Colorectal Adenocarcinoma, Systemic Inflammation, TNF AlphaArmsVery Low Carbohydrate Diet
3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 6 syntheses or guidelines pooled it, 479 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Review
  9. Review
  10. Review
  11. Role of itaconate in intestinal disease (Review).International journal of molecular medicine · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Lypd6b depletion promotes CD8Nature communications · 2025
    Article
  20. Article

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Audrey LasryThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Adar ZingerThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Yinon Ben-NeriahThe Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors remains unclear. Whereas a minority of solid tumors are associated with overt inflammation, long-term treatment with non-steroidal anti-inflammatory drugs is remarkably effective in reducing cancer rate and death. This indicates that inflammation might have many as-yet-unrecognized facets, among which an indolent course might be far more prevalent than previously appreciated. In this Review, we explore the various inflammatory processes underlying the development and progression of colorectal cancer and discuss anti-inflammatory means for its prevention and treatment.

Indexed as

InflammationAdenocarcinomaAdenomaAnimalsAnti-Inflammatory Agents, Non-SteroidalCarcinogenesisColorectal NeoplasmsDisease ProgressionDNA DamageDysbiosisGastrointestinal MicrobiomeHumansImmunity, InnateImmunity, MucosalInflammatory Bowel DiseasesInterleukin-1betaAnti-Inflammatory Agents, Non-SteroidalInterleukin-1betaJanus KinasesProgrammed Cell Death 1 ReceptorReceptors, Interleukin-6STAT Transcription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID26882261
OpenAlexW2276827481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.